Area of research
Cardiology and Cardiovascular Medicine
Research interest
Research interests include Cardiomyopathy and Myosin Studies, Cardiovascular Function and Risk Factors, Viral Infections and Immunology Research, and Cardiac Fibrosis and Remodeling.
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study
Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial)
Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy
Left Atrial Strain Has Superior Prognostic Value to Ventricular Function and Delayed-Enhancement in Dilated Cardiomyopathy
Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data
Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study
The HFA-PEFF Score Identifies ‘Early-HFpEF’ Phenogroups Associated with Distinct Biomarker Profiles
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the <scp>HOMAGE</scp> trial
Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial
Dyskalemia in People at Increased Risk for Heart Failure: Findings from the Heart ‘OMics’ in AGEing (HOMAGE) Trial
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF
The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy
Post‐discharge arrhythmic risk stratification of patients with acute myocarditis and life‐threatening ventricular tachyarrhythmias
Identification of Sex-Specific Biomarkers Predicting New-Onset Heart Failure
Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial
Implications of Genetic Testing in Dilated Cardiomyopathy
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure
Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach
Value of Speckle Tracking–Based Deformation Analysis in Screening Relatives of Patients With Asymptomatic Dilated Cardiomyopathy
Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy
Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias
Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis
The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis
Macrophage MicroRNA-155 Promotes Cardiac Hypertrophy and Failure
Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy